Losartan Vs Nebivolol Vs the association of both on the progression of aortic root dilation in genotyped Marfan Syndrome: 48 months open label randomized controlled phase III trial
Event:
ESC Congress 2019
Topic:
Pharmacotherapy
Session:
Diseases of the aorta: predictors of events and risk modifiers